Press "Enter" to skip to content

Dmytro Shymkiv said that Darnitsa has successfully completed a number of studies of important medicines in EU laboratories

During the period from 2018 to 2020, the Ukrainian pharmaceutical company “Darnitsa” completed 8 studies of generics – bioequivalent drugs to treat diseases of the heart and central nervous system. Most of the work was done in Ukraine and the final stages of testing were…